Position in TGTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$23,949,425
-$24,039,158 QoQ
Shares Held
720,934
-55.2% QoQ
Ownership
0.471%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,194,153,126 across 259 Biotechnology names. TGTX ranks #36 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in TGTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,949,425 | 720,934 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $47,988,583 | 1,609,815 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $39,532,814 | 1,094,334 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $34,906,876 | 969,905 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $47,743,499 | 1,210,842 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $27,985,262 | 929,743 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $21,489,654 | 918,754 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,366,920 | 470,316 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,572,949 | 563,639 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $12,122,477 | 709,747 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,882,718 | 344,823 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,653,203 | 308,100 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,715,134 | 247,017 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,252,219 | 274,913 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $641,229 | 108,316 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,469,364 | 345,733 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,142,671 | 330,460 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $31,393,301 | 1,652,279 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $59,850,515 | 1,798,393 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $43,494,953 | 1,121,293 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $53,063,137 | 1,100,895 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $92,662,808 | 1,781,292 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $28,380,424 | 1,060,554 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||